Company · CIK 0000887359 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Vericel Corp · VCEL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 SForm 4 → | Aug 14, 4:05 pm EDT | Kevin F McLaughlinDirector | 7,000 | $44.53 | $311,710 | 18,300 | −27.7% | 10b5-1 |
| Aug 12, 2026 MForm 4 → | Aug 14, 4:05 pm EDT | Kevin F McLaughlinDirector | 7,000 | $13.05 | $91,350 | 25,300 | — | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 4:05 pm EDT | Michael HalpinChief Operating Officer | 10,000 | $46.84 | $468,400 | 16,394 | −37.9% | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 5, 4:05 pm EDT | Michael HalpinChief Operating Officer | 10,000 | $16.66 | $166,600 | 26,394 | — | 10b5-1 |
| Jul 30, 2026 SForm 4 → | Jul 31, 4:05 pm EDT | Jonathan SiegalPrincipal Accounting Officer | 4,500 | $48.90 | $220,050 | 1,078 | −80.7% | 10b5-1 |
| Jul 30, 2026 MForm 4 → | Jul 31, 4:05 pm EDT | Jonathan SiegalPrincipal Accounting Officer | 4,500 | $31.51 | $141,810 | 1,578 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 MForm 4 → | Aug 14, 4:05 pm EDT | Kevin F McLaughlinDirector | 7,000 | — | — | 7,000 | — | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 5, 4:05 pm EDT | Michael HalpinChief Operating Officer | 10,000 | — | — | 26,250 | — | 10b5-1 |
| Jul 30, 2026 MForm 4 → | Jul 31, 4:05 pm EDT | Jonathan SiegalPrincipal Accounting Officer | 4,500 | — | — | 3,500 | — | 10b5-1 |